Table 2 Clinical information of subjects in the standard and study groups
From: Can probiotics play a role in Helicobacter pylori (H. Pylori) eradication?
Items | Standard therapy group (N = 59) | Study therapy group (N = 100) | P value |
|---|---|---|---|
Age (year) | 42.15 ± 13.28 | 41.23 ± 11.72 | 0.660 |
Weight (kg) | 80.49 ± 15.06 | 76.34 ± 17.40 | 0.116 |
Height (cm) | 163.59 ± 7.58 | 162.02 ± 9.87 | 0.262 |
BMI (kg/m2) | 30.20 ± 6.17 | 29.27 ± 7.03 | 0.390 |
Gender (males: females) | 18 (30.50%): 41 (69.50%) | 34 (34.00%): 66 (66.00%) | 0.650 |
Diabetic (yes: no) | 8 (13.60%): 51 (86.40%) | 21 (21.00%): 79 (79.00%) | 0.241 |
Diarrhea after antibiotic (yes: no) | 14 (25.50%): 41 (74.50%) | 9 (9.50%): 86 (90.50%) | 0.009* |